Mirum Pharmaceuticals, Inc.: Revision history

14 August 2022

• curprev 11:2811:28, 14 August 2022 103.126.60.198 talk 653 bytes +11 No edit summary undo

13 August 2022

• curprev 12:1812:18, 13 August 2022 109.180.50.163 talk 642 bytes +15 No edit summary undo

30 July 2022

• curprev 08:0508:05, 30 July 2022 >Chris 627 bytes +627 Created page with "Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasi..."